| DelveInsight The H. pylori infection market is evolving as treatment strategies shift toward optimized, targeted combination therapies, including triple- and quadruple-drug regimens, bismuth-based ...

The H. pylori infection market is evolving as treatment strategies shift toward optimized, targeted combination therapies, including triple- and quadruple-drug regimens, bismuth-based therapies ...

A 10-day dual regimen of vonoprazan and amoxicillin is noninferior to bismuth quadruple therapy for Helicobacter pylori ...

A doctor yesterday reminded people not to take certain types of drugs before getting a stool antigen test for Helicobacter pylori amid a one-time government-funded testing program for people aged 45 ...

The findings of a new study suggest a possible association between H. pylori infection and the pathophysiology of vitiligo. Based on this link, H. pylori eradication therapy may serve as ...

CPIX reports significant revenue growth and global expansion, while navigating increased expenses and financial commitments.

Vibativ, Sancuso, and new Talicia brand led revenue gains, with initial Talicia sales commencing in Q4. Balance Sheet ...

I would no longer need to take the above medications.

Good afternoon, and welcome to Cumberland Pharmaceuticals 2025 Financial Report and Company Update. This call is being recorded at the company's request and will be archived on its website for 1 year ...

Gastric cancer remains the fifth leading cause of cancer-related deaths worldwide. Although its overall incidence has declined, early-onset cases-diagnosed before age 50-display unique biological and ...

Most men have about a 90% improvement in prostate symptoms immediately after the procedure, which was then reduced to about 50% improvement over their baseline after five years. UroLift is very ...